A clinical trial is testing whether an existing drug could benefit patients with Alzheimer’s disease, in hopes of making ...

The most effective drug for Alzheimer’s will be blocked for use on the NHS on Wednesday. Regulators are expected to declare ...

Britain's National Health Service (NHS) will block Eli Lilly's Alzheimer's drug donanemab on Wednesday, deeming it too ...

In the heart of Seattle, some of the world’s most brilliant minds study the brain at the Allen Institute, where researchers ...

Alzheimer’s patients are set to find out whether a new drug could become available in the UK as health regulators are poised ...

An Alzheimer's drug deemed the "best ever" is set to be blocked for NHS use due to its high cost. Donanemab, manufactured by ...

U.K. regulators will reportedly recommend the NHS not cover Eli Lilly’s (LLY) donanemab for the treatment of early ...

Roche drops a third Alzheimer’s candidate this year, terminating a partnership with UCB just four years after agreeing to ...

Donanemab has been described as a game-changer for Alzheimer's, with research showing it slowed its progressions by 35 per ...

In late 2022, the results of a groundbreaking stage three trial for a ‘miracle’ new Alzheimer’s drug lecanemab were hailed as ...

Politicians, like everyone else, age. Some will develop Alzheimer's disease or dementia. How worried should we be about ...